Trials / Completed
CompletedNCT04532385
Effect of Green Tea Extract on Lipids in Patients With Type 2 Diabetes
Effect of a 12-week Administration of Green Tea Extract on Lipids in Patients With Type 2 Diabetes
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Centro Universitario de Ciencias de la Salud, Mexico · Academic / Other
- Sex
- All
- Age
- 40 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The main objectives of this study were to evaluate the effect of a 12-week supplementation with GTE (400 mg every 12 hours) on serum lipids, arterial stiffness and inflammatory cytokines in patients with T2DM.
Detailed description
A 12 week randomized double-blind, placebo-controlled trial was conducted in patients with T2DM to evaluate the effect of green tea extract (sunphenon 90D, TAIYO international, Minneapolis, US) at a 400 mg/12 hrs dose or calcined magnesia (400 mg/12 hrs) on lipids, anthropometric variables, arterial stiffness and inflammatory cytokines.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Green tea extract | 400 mg capsule |
| DIETARY_SUPPLEMENT | Placebo | 400 mg capsule |
Timeline
- Start date
- 2018-06-12
- Primary completion
- 2019-01-14
- Completion
- 2019-01-14
- First posted
- 2020-08-31
- Last updated
- 2020-08-31
Locations
1 site across 1 country: Mexico
Source: ClinicalTrials.gov record NCT04532385. Inclusion in this directory is not an endorsement.